In HCC, GOLM1 upregulates the expression of PD-L1 in cancer cells through the deubiquitination of PD-L1, which is mediated by the enzyme deubiquitination, thereby benefiting cancer cells to escape from immune cells [22]. Here, CD274 is linked to cancer.